Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the Difference
|
May 26, 2026 |
|
Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke Prevention
|
May 26, 2026 |
|
Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?
|
Apr 30, 2026 |
|
Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa Inhibition
|
Apr 29, 2026 |
|
Caterina Garone, MD, PhD - From Clinical Clues to a Confirmatory Diagnosis: Recognising Thymidine Kinase 2 Deficiency Across the Age Spectrum
|
Apr 15, 2026 |
|
Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?
|
Mar 06, 2026 |
|
Sara Mariotto, MD, PhD - Beyond Myasthenia Gravis: What Are We Learning About FcRn Inhibitors in Other Rare Neuroimmunological Disorders?
|
Jan 07, 2026 |
|
Colin Russell, PhD / John Watkins, MBBCh, BSc - A Shot in the Arm: Leveraging Combination Vaccines for Global Health Impact
|
Dec 17, 2025 |
|
James F. Howard Jr, MD - Direct From San Francisco: Emerging Data and Expert Perspectives on Targeted Therapies for gMG
|
Nov 21, 2025 |
|
Mike Sharma, MD, MSc, FRCPC - Challenging the Status Quo in Secondary Stroke Prevention: Current Perspectives on the Potential of Factor XIa Inhibition
|
Nov 21, 2025 |
|
Patrick Vermersch, MD, PhD - Stripped Back: CNS Inflammation and the Potential for Meaningful Therapeutic Progress in Non-Relapsing Forms of Multiple Sclerosis
|
Oct 30, 2025 |
|
Bernhard Suter, MD - Rett Syndrome Uncovered: An International Exchange on Recognition, Monitoring, and Emerging Therapies
|
Oct 16, 2025 |
|
Richard B. Lipton, MD - Overcoming the Disconnects Between Recommendations and Reality in Acute Migraine Treatment: Patient and Provider Perspectives on Communication and Collaboration
|
Sep 30, 2025 |
|
Richard A. Lewis, MD - Navigating the Evolving CIDP Treatment Landscape: Expert Perspectives on the Therapeutic Potential of Complement Inhibition
|
Sep 05, 2025 |
|
Heinz Wiendl, MD - Neurology Updates From the European Meeting in Helsinki (June 2025)
|
Aug 20, 2025 |
|
Saiju Jacob, MD, DPhil, FRCP, FAAN - The Value of Disease Control in gMG: The Latest Data Evaluating Patient Needs and Treatment Outcomes as They Emerge From Helsinki
|
Aug 04, 2025 |
|
Angela Kay Fitch, MD, FACP, MFOMA - Separating Signal From Noise: Overcoming the Challenges of Obesity Management in Real-World Clinical Practice
|
Aug 04, 2025 |
|
Laurent Servais, MD, PhD - Eligible for Gene Therapy? The Complexity and Therapeutic Implications of Anti-AAV Antibodies
|
Jul 21, 2025 |
|
Ashkan Shoamanesh, MD, FRCPC - Can We Find a New Way Forward in Secondary Stroke Prevention? Exploring the Rationale and Potential Roles for Factor XIa Inhibition
|
Jun 30, 2025 |
|
Luis Querol, MD, PhD - 2025 Congress Highlights From Edinburgh, Scotland: Breaking Down the Data Driving Novel Therapeutic Developments in CIDP
|
Jun 30, 2025 |
|
Heinz Wiendl, MD - Myasthenia Gravis Under the Microscope: 2025 Insights From The Hague
|
Jun 23, 2025 |
|
Nicholas J. Silvestri, MD, FAAN - From Established to Emerging Therapies: Expert Perspectives on the Latest Evidence Base on FcRn Inhibitors for gMG
|
Apr 25, 2025 |
|
Mike Sharma, MD, MSc, FRCPC - Can We Set a New Standard of Care for Secondary Stroke Prevention? Evaluating Current Gaps and Future Goals
|
Apr 21, 2025 |
|
Gavin Giovannoni, MBBCh, PhD - Navigating and Pioneering High-Efficacy DMT Strategies: Optimizing Patient Outcomes in Multiple Sclerosis
|
Apr 02, 2025 |
|
James F. Howard Jr, MD - Beyond FcRn and Complement Inhibitors: Why We Need Novel Treatment Options for Generalized Myasthenia Gravis
|
Mar 26, 2025 |
|
Serdar Dalkilic, MD - Menstruation Triggering Severe Unexplained Abdominal Pain: Could It Be Acute Hepatic Porphyria?
|
Jan 09, 2025 |
|
Elena Pischik, MD, PhD - Acute Polyneuropathy With Abdominal Pain: Could It be Acute Hepatic Porphyria?
|
Jan 09, 2025 |
|
Olivier Bonnot, MD, PhD - Acute Psychosis: When to Suspect Acute Hepatic Porphyria
|
Jan 03, 2025 |
|
Darren M. Brenner / Benoît Coffin - If I'd Known Then What I Know Now: Recognising My First AHP Patient
|
Jan 02, 2025 |
|
Darren M. Brenner, MD - If I'd Known Then What I Know Now: Recognising My First AHP Patient (Rebroadcast)
|
Dec 27, 2024 |
|
Pushpa Narayanaswami, MD, FAAN - Cutting Through the Congress Cacophony on Generalised Myasthenia Gravis: Expert Honing of the Latest Data
|
Dec 12, 2024 |
|
Ffion Davies, MBChB, FRCPCH, FRCEM - Managing Major Bleeding in Patients Receiving DOACs: Data, Developments, and Decision-Making in the ED
|
Nov 08, 2024 |
|
Bruce A C Cree, MD, PhD, MAS - BTK Inhibition and Beyond: Novel Therapies in MS
|
Oct 25, 2024 |
|
Angela Fitch, MD, FACP, MFOMA - This Cannot Weight: A Specialist Guide to Weight Management and Obesity Associated With Emotional Eating Behaviours
|
Oct 25, 2024 |
|
Jiwon Oh, MD, PhD, FRCPC - Navigating the High-Efficacy DMT Landscape in MS: Integrating New Data and Real-World Evidence
|
Sep 30, 2024 |
|
Deborah Siegal, MD, MSc, FRCPC / Richard Body, MBChB, FRCEM, PhD - Turn the Bleed Around: Expert Perspectives on the Evolving Evidence for Management of Factor Xa Inhibitor-Associated Life-Threatening Bleeding
|
Sep 30, 2024 |
|
Jacqueline S. Garcia, MD - Small Words, Big Differences: Best Practices in Supportive Care for Patients With AML
|
Aug 22, 2024 |
|
Isabel Conceição, MD - Prioritizing Patient-Centered Care for ATTR: Expert Perspectives on the Evolution of Data and Decision-Making
|
Jul 22, 2024 |
|
Carlo Antozzi, MD - From Helsinki: Expert Perspectives on the Next Generation of Clinical Evidence for FcRn Inhibitors in Myasthenia Gravis
|
Jul 10, 2024 |
|
Michael Thorpy, MD - When Sleep Is Exhausting: Improving Diagnosis and Outcomes in Patients With Idiopathic Hypersomnia
|
Jul 03, 2024 |
|
Phyllis C. Zee, MD, PhD - Sleep, Heart, Brain: What Promotes and How to Reduce Cardiovascular Risk in Patients With Narcolepsy
|
Jul 03, 2024 |
|
Xavier Montalban, MD, PhD - Multiple Sclerosis and Bruton’s Tyrosine Kinase Inhibitors: Therapeutic Potential Beyond Biologics?
|
May 30, 2024 |
|
Ali Aamer Habib, MD - Neuroimmunology Matters: A Specific Review of Emerging Targeted Strategies for Generalised Myasthenia Gravis
|
Mar 26, 2024 |
|
Nils Erik Gilhus, MD, PhD - Disruption at the Neuromuscular Junction: Relevance of Autoantibodies to Therapy in Generalised Myasthenia Gravis
|
Mar 05, 2024 |
|
Carel le Roux, MD, PhD - Prioritising Obesity Care in Our Clinical Practices: Why We Must and How We Can
|
Jan 22, 2024 |
|
Laurent Servais, MD, PhD - Catch Them Before They Fall: A Call to Action for Comprehensive Testing for Hypotonia in Paediatric Patients
|
Jan 03, 2024 |
|
Andreea Ciudin, MD, PhD - Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on the Modernisation of Obesity Care
|
Dec 21, 2023 |
|
Laura Obici, MD - Taking Action to Improve the Patient Journey With Transthyretin Amyloidosis (ATTR): Shared Perspectives From Patients and Providers
|
Dec 01, 2023 |
|
Jacqueline Turner, MSc - Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
|
Sep 05, 2023 |
|
Nicholas Johnson, MD, MSci, FAAN - Advancing Management of Limb-Girdle Muscular Dystrophy: Why a Genetic Diagnosis Is Needed
|
Jul 31, 2023 |
|
P. James B. Dyck, MD - When ATTR Amyloidosis Strikes a Nerve: Best Practices in Timely Suspicion, Diagnosis, and Management of ATTR-Polyneuropathy
|
Jul 17, 2023 |
|
Michael Thorpy, MD - Dual Duty: Protecting Cardiovascular Health in Patients With Narcolepsy
|
Jul 06, 2023 |
|
James F. Howard Jr, MD - Complement-Mediated Attack of the Neuromuscular Junction in gMG: The C5 Inhibitors
|
May 31, 2023 |
|
Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know More
|
Feb 03, 2023 |
|
Shimu Khamlichi, BSc, ClinPsyD - Protecting the Mental Health of People Living With HIV
|
Dec 28, 2022 |
|
Graeme C Black, OBE, DPhil, FRCOphth, FMedSci - Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
|
Dec 14, 2022 |
|
Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 Diabetes
|
Dec 05, 2022 |
|
Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs
|
Dec 05, 2022 |
|
Paolo Ventura, MD - Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
|
Nov 23, 2022 |
|
Managing Generalised Myasthenia Gravis: A Tale of Two Targets
|
Aug 10, 2022 |
|
The Fear of Disappearing, the Fight to Stay Present': Understanding the Needs of Patients With Alzheimer's Disease
|
May 24, 2022 |
|
Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real World
|
May 24, 2022 |
|
Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
|
May 20, 2022 |
|
Treatment Goals in Systemic Lupus Erythematosus: How Are We Raising the Bar?
|
May 06, 2022 |
|
Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
|
Mar 29, 2022 |
|
Evolving Therapies in Multiple Sclerosis: BTK Inhibitors
|
Mar 29, 2022 |